Download PDF
Am J Perinatol 2024; 41(S 01): e2376-e2382
DOI: 10.1055/a-2113-8733
Original Article

Validation and Feasibility of the Postnatal Growth and Retinopathy of Prematurity Retinal Screening Criteria at a Level IV Tertiary Care Neonatal Intensive Care Unit

Barbara Johnson 
1   Department of Pediatrics, Neonatal Perinatal Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma
,
Abhishek Makkar
1   Department of Pediatrics, Neonatal Perinatal Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma
,
Rachel Sessler
1   Department of Pediatrics, Neonatal Perinatal Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma
,
Lise DeShea
1   Department of Pediatrics, Neonatal Perinatal Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma
,
R Michael Siatkowski
2   Department of Ophthalmology and Dean McGee Eye Institute, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma
,
Faizah N. Bhatti 
1   Department of Pediatrics, Neonatal Perinatal Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma
2   Department of Ophthalmology and Dean McGee Eye Institute, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma
› Author Affiliations Funding This work was supported by the Department of Pediatrics, University of Oklahoma Health Sciences Center. This study's use of REDCap was supported in part by Oklahoma Shared Clinical and Translational Resource (OSCTR), NIH grant U54GM104938, and in part by an unrestricted grant from Research to Prevent Blindness, Inc., NY, NY (RMS, FB).
› Further Information
Also available at
    Permissions and Reprints

Abstract

Objective Retinopathy of prematurity (ROP) is detected in preterm infants by standardized screening programs, but in general, they have poor sensitivity. The Postnatal Growth and Retinopathy of Prematurity (G-ROP) algorithm uses weight gain to predict ROP superior reported sensitivity. Our objectives are to (1) independently validate the sensitivity of G-ROP criteria for the detection of ROP in infants born at >28 weeks' gestation in a tertiary care unit in the United States and (2) to calculate the cost savings associated with a potential reduction in examinations.

Study Design This is a retrospective analysis of retinal screening examination data, with post-hoc application of G-ROP criteria to determine whether G-ROP criteria had acceptable sensitivity and specificity in diagnosing Type 1 and Type 2 ROP. All infants born at >28 weeks who were screened by current American Academy of Pediatric Ophthalmologists/American Academy of Pediatrics guidelines at Oklahoma Children's Hospital at the University of Oklahoma Health Sciences Center, between 2014 and 2019, were included. Subset analysis of infants screened by second tier criteria was also performed. Potential cost savings were estimated by analyzing frequency of billing codes. And by calculating the number of infants who could have potentially been spared examination.

Results The G-ROP criteria had 100% sensitivity in detecting type 1 and 87.6% sensitivity in detecting type 2 ROP, which would have reduced infants screened by 50%. All infants in the second tier who would require treatment were detected. A cost saving of 49% was projected.

Conclusion The G-ROP criteria are easy to apply in real-world setting, thus establishing feasibility. The algorithm identified all cases of type 1 ROP; however, some cases of type 2 ROP were not detected. The annual savings in hospital examination cost by using these criteria would be 50%. Therefore, G-ROP criteria can safely be used to screen for ROP and may reduce the number of unnecessary examinations.

Key Points

  • The G-ROP screening criteria are safe and predict 100% of treatment warranted ROP.

  • Adoption of G-ROP criteria is feasible for level IV NICUs.

  • Adoption of G-ROP screening guidelines will result in significant cost savings.

Keywords

retinopathy of prematurity - standardized screening programs - cost analysis - level IV NICU

Authors' Contributions

B.J. was responsible for acquisition and interpretation of data, revision of the article, and final approval.


A.M. was responsible for conception and design, interpretation of data, drafting and revision of the article, and final approval.


R.S. was responsible for acquisition and interpretation of data, revision of article, and final approval.


L.D. was responsible for analysis and interpretation of data, revision of article, and final approval.


R.M.S. was responsible for the interpretation of data, drafting and revision of article, and final approval.


F.B. was responsible for conception and design, acquisition, and interpretation of data, drafting and revision of article, and final approval.




Publication History

Received: 16 February 2023

Accepted: 19 June 2023

Accepted Manuscript online:
20 June 2023

Article published online:
24 July 2023

© 2023. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Fierson WM. American Academy of Pediatrics Section on Ophthalmology, American Academy of Ophthalmology, American Association for Pediatric Ophthalmology and Strabismus, American Association of Certified Orthoptists. Screening examination of premature infants for retinopathy of prematurity. Pediatrics 2018; 142 (06) 12
    CrossrefPubMedSearch in Google Scholar
  • 2 Early Treatment for Retinopathy of Prematurity Cooperative Group. Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial. Arch Ophthalmol 2003; 121 (12) 1684-1694
    CrossrefPubMedSearch in Google Scholar
  • 3 Fierson WM. American Academy of Pediatrics Section on Ophthalmology, American Academy of Ophthalmology, American Association for Pediatric Ophthalmology and Strabismus, American Association of Certified Orthoptists. Screening examination of premature infants for retinopathy of prematurity. Pediatrics 2013; 131 (01) 189-195
    CrossrefPubMedSearch in Google Scholar
  • 4 Quinn GE, Ying GS, Bell EF. et al; G-ROP Study Group. Incidence and early course of retinopathy of prematurity: secondary analysis of the Postnatal Growth and Retinopathy of Prematurity (G-ROP) Study. JAMA Ophthalmol 2018; 136 (12) 1383-1389
    CrossrefPubMedSearch in Google Scholar
  • 5 Binenbaum G, Tomlinson LA, de Alba Campomanes AG. et al; Postnatal Growth and Retinopathy of Prematurity (G-ROP) Study Group. Validation of the postnatal growth and retinopathy of prematurity screening criteria. JAMA Ophthalmol 2020; 138 (01) 31-37
    PubMedSearch in Google Scholar
  • 6 Suelves A, Shulman J, Gaffar M, Jain A, Hartnett ME. Practice patterns in ophthalmic examinations for retinopathy of prematurity in the United States. EC Ophthalmology 2015; 2 (03) 114-122
    PubMedSearch in Google Scholar
  • 7 Mitchell AJ, Green A, Jeffs DA, Roberson PK. Physiologic effects of retinopathy of prematurity screening examinations. Adv Neonatal Care 2011; 11 (04) 291-297
    CrossrefPubMedSearch in Google Scholar
  • 8 Clarke WN, Hodges E, Noel LP, Roberts D, Coneys M. The oculocardiac reflex during ophthalmoscopy in premature infants. Am J Ophthalmol 1985; 99 (06) 649-651
    CrossrefPubMedSearch in Google Scholar
  • 9 Wade KC, Pistilli M, Baumritter A. et al; e-Retinopathy of Prematurity Study Cooperative Group. Safety of retinopathy of prematurity examination and imaging in premature infants. J Pediatr 2015; 167 (05) 994-1000.e2
    CrossrefPubMedSearch in Google Scholar
  • 10 Wang DN, Lavery K, Dalgleish S, Howlett A, Hill VE, Dotchin SA. Reducing discomfort of eye drops prior to retinal examination in the neonatal intensive care unit. J Perinatol 2020; 40 (12) 1857-1862
    CrossrefPubMedSearch in Google Scholar
  • 11 Lahoti S, Jones R, Beck KD. et al. Retinopathy of prematurity screening examination and changes in vital signs. Ophthalmic Surg Lasers Imaging Retina 2021; 52 (08) 458-463
    CrossrefPubMedSearch in Google Scholar
  • 12 Binenbaum G, Bell EF, Donohue P. et al; G-ROP Study Group. Development of modified screening criteria for retinopathy of prematurity: primary results from the Postnatal Growth and Retinopathy of Prematurity Study. JAMA Ophthalmol 2018; 136 (09) 1034-1040
    CrossrefPubMedSearch in Google Scholar
  • 13 Bal S, Ying GS, Tomlinson L, Binenbaum G, Postnatal G. Retinopathy of Prematurity Study G. Association of weight gain acceleration with risk of retinopathy of prematurity. JAMA Ophthalmol 2019; 137 (11) 1301-1305
    CrossrefPubMedSearch in Google Scholar
  • 14 Binenbaum G, Tomlinson LA, de Alba Campomanes AG. et al. Validation of the postnatal growth and retinopathy of prematurity screening criteria. JAMA Ophthalmol 2019; 138 (01) 31-37
    CrossrefPubMedSearch in Google Scholar
  • 15 Zupancic JAF, Ying GS, de Alba Campomanes A, Tomlinson LA, Binenbaum G. G-ROP Study Group. Evaluation of the economic impact of modified screening criteria for retinopathy of prematurity from the Postnatal Growth and ROP (G-ROP) study. J Perinatol 2020; 40 (07) 1100-1108
    CrossrefPubMedSearch in Google Scholar
  • 16 Shiraki A, Fukushima Y, Kawasaki R. et al. Retrospective Validation of the Postnatal Growth and Retinopathy of Prematurity (G-ROP) criteria in a Japanese cohort. Am J Ophthalmol 2019; 205: 50-53
    CrossrefPubMedSearch in Google Scholar
  • 17 Vinayahalingam N, McDougall J, Ahrens O, Ebneter A. Retrospective validation of the postnatal Growth and Retinopathy of Prematurity (G-ROP) criteria in a Swiss cohort. BMC Ophthalmol 2022; 22 (01) 19
    CrossrefPubMedSearch in Google Scholar
  • 18 Warren CC, Young JB, Goldberg MR, Connor TB, Kassem IS, Costakos DM. Findings in persistent retinopathy of prematurity. Ophthalmic Surg Lasers Imaging Retina 2018; 49 (07) 497-503
    CrossrefPubMedSearch in Google Scholar
  • 19 Wood EH, Ji MH, Rao P. et al. Management of Type 2 retinopathy of prematurity or less in infants aged 45 weeks postmenstrual age or older. Ophthalmic Surg Lasers Imaging Retina 2021; 52 (12) 636-641
    CrossrefPubMedSearch in Google Scholar
  • 20 Martin JA, Hamilton BE, Osterman MJK, Driscoll AK. Births: Final Data for 2019. Natl Vital Stat Rep 2021; 70 (02) 1-51
    PubMedSearch in Google Scholar
  • 21 Aly HM, Othman HF, Munster C, Das A, Sears J. The US National Trend for Retinopathy of Prematurity. Am J Perinatol 2021; 29 (14) 1569-1576
    PubMedSearch in Google Scholar
  • 22 Hellström A, Hård AL, Engström E. et al. Early weight gain predicts retinopathy in preterm infants: new, simple, efficient approach to screening. Pediatrics 2009; 123 (04) e638-e645
    CrossrefPubMedSearch in Google Scholar
  • 23 Binenbaum G, Ying GS, Quinn GE. et al. The CHOP postnatal weight gain, birth weight, and gestational age retinopathy of prematurity risk model. Arch Ophthalmol 2012; 130 (12) 1560-1565
    CrossrefPubMedSearch in Google Scholar
  • 24 Binenbaum G, Ying GS, Quinn GE. et al; Premature Infants in Need of Transfusion Study Group. A clinical prediction model to stratify retinopathy of prematurity risk using postnatal weight gain. Pediatrics 2011; 127 (03) e607-e614
    CrossrefPubMedSearch in Google Scholar
  • 25 Cao JH, Wagner BD, McCourt EA. et al. The Colorado-retinopathy of prematurity model (CO-ROP): postnatal weight gain screening algorithm. J AAPOS 2016; 20 (01) 19-24
    CrossrefPubMedSearch in Google Scholar